<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04446767</url>
  </required_header>
  <id_info>
    <org_study_id>P.T REC/017/00482.</org_study_id>
    <nct_id>NCT04446767</nct_id>
  </id_info>
  <brief_title>Photobiomodulation With Polarized Light as Adjunctive Treatment in Diabetic Foot Ulcer</brief_title>
  <official_title>Photobiomodulation With Polarized Light as Adjunctive Treatment in Diabetic Foot Ulcer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Princess Nourah Bint Abdulrahman University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of Photobiomodulation With Polarized Light on wound healing and aerobic microflora in&#xD;
      Diabetic Foot Ulcer&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Effect of Photobiomodulation With Polarized Light on wound healing and aerobic microflora in&#xD;
      Diabetic Foot Ulcer both sexes were included and intervention will be given for two months,&#xD;
      wound healing will be assessed by measuring the surface area and the Aerobic microflora will&#xD;
      be isolated and controlled on the basis of bio-gram and antibiogram at the beginning and at&#xD;
      the end of treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 30, 2020</start_date>
  <completion_date type="Actual">September 5, 2020</completion_date>
  <primary_completion_date type="Actual">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Histologic evaluation:</measure>
    <time_frame>two months</time_frame>
    <description>Aerobic microflora will be isolated and controlled on the basis of biogram and antibiogram at the beginning and at the end of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wound assessment</measure>
    <time_frame>two months</time_frame>
    <description>The wound surface area (ulcer size), lenghth and width will measured using Ruler technique</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Wound Healing Disorder</condition>
  <arm_group>
    <arm_group_label>Bioptron light therapy and medical care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bioptron light therapy sessions, about 12 minutes on the foot ulcer 3 sessions per week for about 8 weeks plus medical care in the form of Appropriate day-care and principles of local ulcer therapy, washing and bandaging, use of anti exudative, anti-inflammatory and disinfection solutions will be administered to this group, topical antibiotics will be administered based on bio-gram and antibiogram results</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medical care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Appropriate day-care and principles of local ulcer therapy, washing and bandaging, use of anti exudative, anti-inflammatory and disinfection solutions will be administered to this group, topical antibiotics will be administered based on bio-gram and antibiogram results</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>polarized light</intervention_name>
    <description>bioptron light therapy sessions, about 12 minutes on the foot ulcer 3 sessions per week for about 8 weeks</description>
    <arm_group_label>Bioptron light therapy and medical care</arm_group_label>
    <other_name>bioptron light therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical Care</intervention_name>
    <description>Appropriate day-care and principles of local ulcer therapy, washing and bandaging, use of anti exudative, anti-inflammatory and disinfection solutions will be administered to this group, topical antibiotics will be administered based on bio-gram and antibiogram results</description>
    <arm_group_label>medical care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The patients with diagnosed diabetic foot ulcer lasting at least 4 weeks ( sized from&#xD;
             0.5 to 2 cm&#xD;
&#xD;
          2. Cooperative and mentally stable patients .&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Hepatic patients .&#xD;
&#xD;
          2. Uncontrolled hypertension .&#xD;
&#xD;
          3. Uncontrolled diabetic patients with HbA1c&gt;8.5% .&#xD;
&#xD;
          4. Neurological disorders .&#xD;
&#xD;
          5. Musculoskeletal disorders that interfere with program .&#xD;
&#xD;
          6. Previous history or any sign of DVT .&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasr Alaini</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 28, 2020</study_first_submitted>
  <study_first_submitted_qc>June 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2020</study_first_posted>
  <last_update_submitted>February 28, 2021</last_update_submitted>
  <last_update_submitted_qc>February 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mona Mohamed Taha</investigator_full_name>
    <investigator_title>ASSISTANT PROFESSOR</investigator_title>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>foot ulcer</keyword>
  <keyword>polarized light</keyword>
  <keyword>;wound healing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

